Blues promote cost transparency
Five Blues plans collaborate to provide online, consumer-friendly healthcare cost information.
Five Blues health plans are collaborating to provide access to online, consumer-friendly healthcare cost information.
WellPoint, Highmark Inc. (Pennsylvania), Premera Blue Cross (Washington), Blue Cross and Blue Shield of Minnesota and Blue Cross Blue Shield of Michigan, will provide the total estimated cost ranges associated with 39 specific medical procedures performed at a local hospital, outpatient surgery center, free-standing radiology facility or other medical facility.
“It is a collaborative effort to use the same data methodology [developed by WellPoint] and same condition list to present to all members within all Blue Plan locations,” says Debra Miller, a Highmark e-marketing consultant.
The cost information is facility-specific ranges that include everything during the hospital stay, according to Miller. “It is a shopping tool for common elective surgical procedures where the consumer has the ability to shop and the desire to do so because of increasing out-of-pocket costs,” she says.
The roll-out will initially include a limited amount of cost information. Information is being mined from the Blue plans’ claims data paid over the last 12 months, and will be updated every six months.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
